Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Osteopore Ltd. (OSX) Share Price & Analysis

11 Followers

OSX Stock Chart & Stats

A$0.00A$0.00(0.00%)
At close: 12:14 PM GMT+11
AU$0.01AU$0.015AU$0.02AU$0.025Nov 17Jan 9Jan 27Feb 9
Day’s Range
AUD 0.01 - AUD 0.01
52-Week Range
AUD 0.01 - AUD 0.05
Previous Close
AUD 0.01
Volume
N/A
Average Volume (3M)
17.20M
Market Cap
AUD 2.08M
Enterprise Value
AUD 936.72K
Total Cash (Recent Filing)
AUD 1.25M
Total Debt (Recent Filing)
AUD 74.39K
Price to Earnings (P/E)
―
Beta
0.31
Next Earnings
Feb 26, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Revenue has more than doubled across the reported period, indicating expanding commercial activity and growing adoption of Osteopore’s regenerative biomaterial products. If this trajectory continues, greater scale could improve operating leverage and support the company’s longer-term path toward profitability.

Healthy Gross Margin

A gross margin near 53% provides evidence that the company’s products retain meaningful value after direct costs. This gives Osteopore a potentially constructive base for future operating improvement, provided revenue growth continues and overhead and development spending become more efficiently absorbed.

Debt Reduction

The sharp reduction in debt lowers contractual leverage and should reduce exposure to interest and refinancing pressure relative to the prior year. This improvement strengthens the capital structure, even though the company still faces broader balance-sheet and funding challenges.

Bears Say

Persistent Unprofitability

Osteopore has not yet converted revenue growth into sustainable earnings, and the sizeable 2025 net loss remains the central fundamental weakness. Continued losses can consume capital, restrict reinvestment capacity, and make future expansion dependent on successful execution and external funding.

Negative Cash Generation

Consistently negative operating and free cash flow show that the business is not currently self-funding its operations. Ongoing cash burn can require additional financing, reduce flexibility to invest in commercialization, and increase the consequences of any delay in achieving break-even.

Negative Shareholders’ Equity

Negative equity indicates that accumulated obligations exceed the reported shareholder capital base, weakening financial resilience. It can constrain financing flexibility and heighten refinancing risk, leaving the company more reliant on external capital while it works toward sustainable profitability.

Osteopore Ltd. News

OSX FAQ

What was Osteopore Ltd.’s price range in the past 12 months?
Osteopore Ltd. lowest share price was AU$0.01 and its highest was AU$0.05 in the past 12 months.
What is Osteopore Ltd.’s market cap?
Osteopore Ltd.’s market cap is AU$2.08M.
When is Osteopore Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Osteopore Ltd.’s earnings last quarter?
Osteopore Ltd. released its earnings results on Aug 31, 2026. The company reported -AU$0.004 earnings per share for the quarter.
Is Osteopore Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Osteopore Ltd. pay dividends?
Osteopore Ltd. does not currently pay dividends.
What is Osteopore Ltd.’s EPS estimate?
Osteopore Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Osteopore Ltd. have?
Osteopore Ltd. has 693,592,900 shares outstanding.
What happened to Osteopore Ltd.’s price movement after its last earnings report?
Osteopore Ltd. reported an EPS of -AU$0.004 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Osteopore Ltd.?
Currently, no hedge funds are holding shares in AU:OSX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology